Sabra Historical Financial Ratios

SBRA Stock

USD 18.91 0.07 0.37%

Sabra Healthcare is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 12.46, Free Cash Flow Yield of 0.0957, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.3 will help investors to properly organize and evaluate Sabra Healthcare REIT financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Sabra Financial Ratios Analysis

Sabra Healthcare REITFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Sabra Healthcare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Sabra financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Sabra Healthcare history.

Sabra Healthcare Financial Ratios Chart

At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 1.53, whereas Dividend Yield is forecasted to decline to 0.07.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding Net Profit Margin

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Sabra Healthcare REIT stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Sabra Healthcare sales, a figure that is much harder to manipulate than other Sabra Healthcare REIT multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Sabra Healthcare REIT dividend as a percentage of Sabra Healthcare stock price. Sabra Healthcare REIT dividend yield is a measure of Sabra Healthcare stock productivity, which can be interpreted as interest rate earned on an Sabra Healthcare investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Net Profit Margin

The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.

Most ratios from Sabra Healthcare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.0886	0.0965	0.0841	0.0653
Price To Sales Ratio	5.21	4.59	5.1	10.03

Dividend Yield Price To Sales Ratio

Sabra Healthcare fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		0.01	0.61	-0.24	-0.41	-0.01	-0.7	0.57	0.61	0.99	-0.05	-0.2	0.14	-0.14	-0.12	-0.12	-0.18	0.59	0.35	0.99	-0.18	0.0	0.48	0.94	0.21	0.03
Dividend Yield	0.01		-0.59	-0.32	0.24	-0.06	-0.08	-0.09	-0.59	0.07	-0.14	0.56	-0.08	0.04	0.07	-0.09	0.33	-0.06	0.3	-0.04	-0.2	-0.26	-0.2	-0.13	-0.27	-0.26
Ptb Ratio	0.61	-0.59		-0.06	-0.67	0.1	-0.32	0.46	1.0	0.58	0.17	-0.72	0.22	-0.06	-0.18	-0.16	-0.35	0.45	-0.14	0.62	-0.08	0.08	0.49	0.7	0.43	0.1
Days Sales Outstanding	-0.24	-0.32	-0.06		0.35	0.22	0.39	-0.05	-0.06	-0.21	0.32	-0.28	0.33	0.38	-0.37	-0.4	-0.08	-0.1	-0.14	-0.19	0.16	-0.35	0.1	-0.14	0.46	-0.37
Book Value Per Share	-0.41	0.24	-0.67	0.35		-0.01	0.29	-0.26	-0.67	-0.36	-0.05	0.32	0.23	0.54	-0.23	-0.17	-0.13	-0.29	0.47	-0.34	0.47	-0.2	-0.17	-0.56	-0.05	-0.23
Free Cash Flow Yield	-0.01	-0.06	0.1	0.22	-0.01		0.25	-0.7	0.1	-0.04	0.97	-0.31	-0.25	-0.04	0.23	0.24	0.23	-0.71	-0.4	-0.03	0.11	0.08	-0.63	0.21	-0.3	0.06
Operating Cash Flow Per Share	-0.7	-0.08	-0.32	0.39	0.29	0.25		-0.37	-0.32	-0.69	0.4	0.01	0.27	0.39	-0.27	-0.19	-0.14	-0.4	-0.53	-0.74	0.39	-0.2	-0.26	-0.58	0.04	-0.2
Capex To Depreciation	0.57	-0.09	0.46	-0.05	-0.26	-0.7	-0.37		0.46	0.6	-0.61	-0.16	0.52	0.19	-0.48	-0.53	-0.44	1.0	0.4	0.58	-0.09	-0.24	0.97	0.4	0.71	-0.2
Pb Ratio	0.61	-0.59	1.0	-0.06	-0.67	0.1	-0.32	0.46		0.58	0.17	-0.72	0.22	-0.06	-0.18	-0.16	-0.35	0.45	-0.14	0.62	-0.08	0.08	0.49	0.7	0.43	0.1
Ev To Sales	0.99	0.07	0.58	-0.21	-0.36	-0.04	-0.69	0.6	0.58		-0.06	-0.21	0.2	-0.08	-0.19	-0.21	-0.16	0.62	0.4	0.98	-0.19	-0.09	0.52	0.92	0.26	-0.06
Free Cash Flow Per Share	-0.05	-0.14	0.17	0.32	-0.05	0.97	0.4	-0.61	0.17	-0.06		-0.37	-0.08	0.06	0.07	0.09	0.13	-0.63	-0.5	-0.07	0.18	-0.01	-0.52	0.21	-0.17	-0.02
Roic	-0.2	0.56	-0.72	-0.28	0.32	-0.31	0.01	-0.16	-0.72	-0.21	-0.37		-0.21	-0.01	0.23	0.37	0.02	-0.12	0.09	-0.22	0.23	0.26	-0.3	-0.3	-0.48	0.26
Inventory Turnover	0.14	-0.08	0.22	0.33	0.23	-0.25	0.27	0.52	0.22	0.2	-0.08	-0.21		0.69	-0.98	-0.78	-0.69	0.49	0.11	0.15	0.32	-0.55	0.59	0.07	0.6	-0.53
Net Income Per Share	-0.14	0.04	-0.06	0.38	0.54	-0.04	0.39	0.19	-0.06	-0.08	0.06	-0.01	0.69		-0.61	-0.46	-0.71	0.15	0.17	-0.09	0.7	-0.21	0.32	-0.23	0.51	-0.2
Days Of Inventory On Hand	-0.12	0.07	-0.18	-0.37	-0.23	0.23	-0.27	-0.48	-0.18	-0.19	0.07	0.23	-0.98	-0.61		0.78	0.59	-0.45	-0.08	-0.12	-0.2	0.57	-0.54	-0.06	-0.56	0.55
Payables Turnover	-0.12	-0.09	-0.16	-0.4	-0.17	0.24	-0.19	-0.53	-0.16	-0.21	0.09	0.37	-0.78	-0.46	0.78		0.26	-0.5	-0.3	-0.12	0.06	0.9	-0.61	-0.04	-0.66	0.88
Average Inventory	-0.18	0.33	-0.35	-0.08	-0.13	0.23	-0.14	-0.44	-0.35	-0.16	0.13	0.02	-0.69	-0.71	0.59	0.26		-0.41	-0.02	-0.21	-0.69	-0.08	-0.49	-0.11	-0.48	-0.11
Capex To Revenue	0.59	-0.06	0.45	-0.1	-0.29	-0.71	-0.4	1.0	0.45	0.62	-0.63	-0.12	0.49	0.15	-0.45	-0.5	-0.41		0.4	0.59	-0.12	-0.22	0.95	0.42	0.66	-0.18
Cash Per Share	0.35	0.3	-0.14	-0.14	0.47	-0.4	-0.53	0.4	-0.14	0.4	-0.5	0.09	0.11	0.17	-0.08	-0.3	-0.02	0.4		0.41	-0.01	-0.27	0.4	0.06	0.13	-0.28
Pocfratio	0.99	-0.04	0.62	-0.19	-0.34	-0.03	-0.74	0.58	0.62	0.98	-0.07	-0.22	0.15	-0.09	-0.12	-0.12	-0.21	0.59	0.41		-0.14	0.02	0.51	0.92	0.25	0.04
Interest Coverage	-0.18	-0.2	-0.08	0.16	0.47	0.11	0.39	-0.09	-0.08	-0.19	0.18	0.23	0.32	0.7	-0.2	0.06	-0.69	-0.12	-0.01	-0.14		0.24	0.0	-0.19	0.13	0.25
Payout Ratio	0.0	-0.26	0.08	-0.35	-0.2	0.08	-0.2	-0.24	0.08	-0.09	-0.01	0.26	-0.55	-0.21	0.57	0.9	-0.08	-0.22	-0.27	0.02	0.24		-0.28	0.04	-0.35	1.0
Capex To Operating Cash Flow	0.48	-0.2	0.49	0.1	-0.17	-0.63	-0.26	0.97	0.49	0.52	-0.52	-0.3	0.59	0.32	-0.54	-0.61	-0.49	0.95	0.4	0.51	0.0	-0.28		0.32	0.82	-0.25
Pfcf Ratio	0.94	-0.13	0.7	-0.14	-0.56	0.21	-0.58	0.4	0.7	0.92	0.21	-0.3	0.07	-0.23	-0.06	-0.04	-0.11	0.42	0.06	0.92	-0.19	0.04	0.32		0.16	0.06
Days Payables Outstanding	0.21	-0.27	0.43	0.46	-0.05	-0.3	0.04	0.71	0.43	0.26	-0.17	-0.48	0.6	0.51	-0.56	-0.66	-0.48	0.66	0.13	0.25	0.13	-0.35	0.82	0.16		-0.33
Income Quality	0.03	-0.26	0.1	-0.37	-0.23	0.06	-0.2	-0.2	0.1	-0.06	-0.02	0.26	-0.53	-0.2	0.55	0.88	-0.11	-0.18	-0.28	0.04	0.25	1.0	-0.25	0.06	-0.33

Click cells to compare fundamentals

Sabra Healthcare Account Relationship Matchups

Sabra Healthcare fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	6.04	5.98	5.21	4.59	5.1	10.03
Dividend Yield	0.084	0.0777	0.0886	0.0965	0.0841	0.0653
Ptb Ratio	1.14	1.05	0.88	0.94	1.18	1.53
Days Sales Outstanding	117.77	133.88	307.7	86.4	58.22	55.31
Book Value Per Share	18.64	16.53	15.43	13.23	12.12	12.46
Free Cash Flow Yield	(0.1)	0.15	0.0933	0.0696	0.0911	0.0957
Operating Cash Flow Per Share	2.01	1.99	1.72	1.63	1.37	1.3
Stock Based Compensation To Revenue	0.0148	0.0132	0.0139	0.0119	0.0122	0.0116
Pb Ratio	1.14	1.05	0.88	0.94	1.18	1.53
Ev To Sales	9.82	9.61	9.85	9.22	8.84	8.81
Free Cash Flow Per Share	1.99	1.21	1.47	1.37	1.3	0.72
Roic	0.0542	0.0415	0.003352	0.0239	0.0366	0.0384
Net Income Per Share	0.37	0.67	(0.52)	(0.34)	0.0595	0.0565
Payables Turnover	1.44	1.82	0.99	1.14	5.13	5.38
Sales General And Administrative To Revenue	0.046	0.0547	0.0609	0.0633	0.0733	0.11
Cash Per Share	4.91	0.53	0.25	0.35	1.99	0.26
Pocfratio	10.72	10.09	8.32	9.09	10.98	17.03
Interest Coverage	2.65	2.4	0.19	1.29	1.94	2.15
Payout Ratio	4.86	2.01	(2.32)	(3.57)	20.17	21.18
Pfcf Ratio	10.72	14.37	9.19	9.09	10.98	14.53
Days Payables Outstanding	253.6	200.21	369.62	319.31	71.19	67.63
Income Quality	5.4	2.56	(3.15)	(4.07)	21.85	22.94
Roe	0.0198	0.0406	(0.0335)	(0.0254)	0.004908	0.004663
Pe Ratio	57.89	25.88	(26.19)	(36.99)	239.84	251.83
Return On Tangible Assets	0.0116	0.0234	(0.0192)	(0.0136)	0.002569	0.00244
Ev To Free Cash Flow	17.07	23.65	16.26	17.5	18.98	24.61
Earnings Yield	0.0173	0.0386	(0.0382)	(0.027)	0.004169	0.003961
Intangibles To Total Assets	0.0167	0.0138	0.009061	0.006982	0.005736	0.00545
Net Debt To E B I T D A	4.57	5.53	13.73	8.21	7.71	12.86
Current Ratio	2.82	2.25	4.57	4.31	0.92	0.87
Tangible Book Value Per Share	18.1	16.13	15.18	13.06	11.99	12.22
Receivables Turnover	3.1	2.73	1.19	4.22	6.27	6.58
Graham Number	12.43	15.8	13.4	10.0	4.03	3.83
Shareholders Equity Per Share	18.64	16.53	15.43	13.23	12.12	12.45

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:

How To Invest In Sabra

Details

Is Sabra Stock a good investment?

Details

What is Sabra Healthcare's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.111

Dividend Share

1.2

Earnings Share

0.41

Revenue Per Share

2.943

Quarterly Revenue Growth

0.107

The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Sabra Historical Financial Ratios

About Sabra Financial Ratios Analysis

Sabra Healthcare Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Net Profit Margin

Sabra Healthcare fundamentals Correlations

Sabra Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sabra Healthcare fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Capex To Revenue	+ 1.0	Capex To Depreciation
Income Quality	+ 1.0	Payout Ratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Pocfratio	+ 0.99	Price To Sales Ratio
Pocfratio	+ 0.98	Ev To Sales

Days Of Inventory On Hand	- 0.98	Inventory Turnover
Payables Turnover	- 0.78	Inventory Turnover
Pocfratio	- 0.74	Operating Cash Flow Per Share
Roic	- 0.72	Pb Ratio
Roic	- 0.72	Ptb Ratio
Average Inventory	- 0.71	Net Income Per Share